Franklin Stuart Friedman - 23 Jun 2022 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role
Director
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Issuer symbol
DCPH
Transactions as of
23 Jun 2022
Transactions value $
$0
Form type
4
Date filed
24 Jun 2022, 16:05
Previous filing
20 Jan 2022
Next filing
19 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DCPH Stock Option (Right to Buy) Award $0 +18.5K $0.00 18.5K 23 Jun 2022 Common Stock 18.5K $13.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in full on June 23, 2023, subject to continued service through such date.